Serum Proteomic Classifier for patients with advanced NSCLC treated with Erlotinib and bevacizumab in first line

---

Autoria(s): Gautschi O.; Dingemans A.C..; Crowe S.; Roder F.; Zappa F.; Pless M.; Brutsche M.; Peters S.; Carbone D.; Smit E.F.

Data(s)	2012
Identificador	http://serval.unil.ch/?id=serval:BIB_3FF51EA59128
Idioma(s)	en
Fonte	ELCC 2012, 3rd European Lung Cancer Conference
Tipo	info:eu-repo/semantics/conferenceObject inproceedings